Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-FU and Calcipotriene for Squamous Cell Carcinoma
NCT04839731Phase 1Unknown
- Sponsor
- Carilion Clinic
- Start
- Apr 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fluorouracil 5% cream and calcipotriol in squamous cell carcinoma (SCC) (3 arms), sponsored by Carilion Clinic. Primary endpoint: Cancer resolution on histopathology. Status: unknown.
02
Drugs
fluorouracil 5% creamcalcipotriol
03
Conditions
squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT04839731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04839731.